US equities
|
NVDA
$182.12
▼-9.00%
MU
$705.98
▼-11.22%
TSLA
$339.18
▼-11.94%
AMD
$429.19
▼-12.19%
SNDK
$874.88
▼-15.67%
SPCX
$123.31
▼-9.27%
AMZN
$259.99
▼-2.27%
AAPL
$342.87
▼-1.90%
NVDA
$182.12
▼-9.00%
MU
$705.98
▼-11.22%
TSLA
$339.18
▼-11.94%
AMD
$429.19
▼-12.19%
SNDK
$874.88
▼-15.67%
SPCX
$123.31
▼-9.27%
AMZN
$259.99
▼-2.27%
AAPL
$342.87
▼-1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
US High Relative Profitability Portfolio ETF Class Shares
(NY:
DUHP
)
41.35
-1.81 (-4.19%)
Delayed Quote
Updated: 1:02 PM EST, Nov 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about US High Relative Profitability Portfolio ETF Class Shares
< Previous
1
2
3
4
Next >
Texas Sues Eli Lilly Over Bribery Allegations: Retail Focuses On Company’s Upbeat Performance
↗
August 12, 2025
Texas Attorney General Ken Paxton alleged that Lilly offered illegal incentives to medical providers in Texas designed to steer providers toward prescribing Lilly’s drugs.
Via
Stocktwits
Topics
Fraud
Law Enforcement
Lawsuit
Gilead Stock Showered With Upgrades, Price Target Hikes After Upbeat Q2, Guidance Lift: Retail’s Turned Exuberant
↗
August 08, 2025
Via
Stocktwits
GM Secures Rare Earth Magnet Supply From Texas Partner Amid Push to Mitigate Tariffs
↗
August 06, 2025
Noveon Magnetics said that it began delivering magnets to support GM's full-size SUVs and trucks in July.
Via
Stocktwits
Topics
Earnings
Economy
World Trade
GM More Than Doubles EV Sales In July Ahead Of Federal Tax Credit Expiry: Chevrolet Equinox EV Leads Pack
↗
August 04, 2025
Via
Stocktwits
Merck’s Full Year Guidance Disappoints Investors But Retail Pins Hopes On $3B Cost-Cutting Plan
↗
July 29, 2025
The $3 billion will be reinvested to support new product launches and its pipeline across multiple therapeutic areas, Merck said.
Via
Stocktwits
Topics
World Trade
GM’s Mary Barra Highlights Efforts To Mitigate Tariff Impact After Q2 Earnings Take Hit: Retail Sees Levies Impact Consumer Spending
↗
July 22, 2025
Via
Stocktwits
Retail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here's What Investors Are Thinking
↗
July 18, 2025
Via
Stocktwits
General Motors, LG Energy Solution JV To Upgrade Spring Hill Facility To Scale Low-Cost Battery Cell Making
↗
July 14, 2025
Via
Stocktwits
BMO Capital Has An Important Take On Gilead Sciences, Retail’s Keeping The Optimism Alive
↗
July 28, 2025
The Supreme Court's Braidwood decision only concretized the power of the Department of Health and Human Services to decide what is necessary preventative care, rather than outright protecting...
Via
Stocktwits
Gilead Gets Analyst Thumbs Up On Market Potential Of HIV-Prevention Injection, But Retail’s Not Ready To Cheer Yet
↗
July 25, 2025
Needham has a $133 price target on the stock, representing an upside of about 17.5% to the stock’s closing price on Thursday.
Via
Stocktwits
Topics
Workforce
GM EV Production To Be Guided By Consumer Demand, Says CFO As Federal Tax Credits Near Expiry
↗
July 22, 2025
GM CFO said that the company’s recent $4 billion investment in U.S. manufacturing over the next two years gives it the necessary capabilities to produce both internal combustion engine and electric...
Via
Stocktwits
Topics
Government
AbbVie Enters Licensing Agreement For IGI Therapeutics’ Experimental Oncology Drug: Retail Cheers
↗
July 10, 2025
Under the terms of the agreement, AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China.
Via
Stocktwits
Topics
Product Recall
Gilead, Global Fund Enter Agreement To Supply HIV Prevention Drug To Low & Lower-Middle-Income Countries
↗
July 09, 2025
Under the agreement, Gilead will supply enough doses of its Lenacapavir drug to reach up to two million people over three years in countries supported by the Global Fund, at no profit to the company.
Via
Stocktwits
Eli Lilly’s Alzheimer’s Drug Gets US FDA Label Update For More Gradual Dosing After Study Shows Reduced Side Effects
↗
July 09, 2025
The U.S. FDA approved Kisunla, an amyloid-targeting therapy, in July 2024 after a study showed that it significantly slowed cognitive and functional decline in Alzheimer’s patients who were less...
Via
Stocktwits
Johnson & Johnson Submits Supplemental Drug Application To FDA For Schizophrenia Drug Caplyta
↗
July 08, 2025
J&J gained access to Caplyta by the acquisition of Intra-Cellular Therapies, Inc., which was completed in April.
Via
Stocktwits
Topics
Government
GM Stock Rises As US Sales Jump 7% In Q2, Powered By Crossovers
↗
July 01, 2025
Chevrolet, the company’s biggest brand, witnessed a 5.7% increase in sales in the quarter to 478,322 units, owing to a jump in sales of its Silverado and Equinox vehicles.
Via
Stocktwits
AbbVie To Acquire Capstan Therapeutics For Up To $2.1 Billion To Boost Immunology Portfolio As Humira Sales Drop: Stock Gains In Morning Trade
↗
June 30, 2025
The acquisition will include Capstan’s lead asset, called CPTX2309, in development for the treatment of B-cell-mediated autoimmune diseases.
Via
Stocktwits
Topics
Intellectual Property
Gilead Stock Rises On US Supreme Court Ruling In Favor Of Health Insurers Covering Preventive Care
↗
June 27, 2025
Jefferies termed the Supreme Court’s ruling an ‘incremental positive’ for Gilead that removes an overhang going into the launch for Yeztugo.
Via
Stocktwits
Trump HHS Pick Robert F. Kennedy Jr.'s Wealth Comes From Family, Law Practice, Oil, Bitcoin
↗
November 27, 2024
Robert F. Kennedy Jr. owes portions of his wealth to his family name, law, cryptocurrency and oil. Here's a look at his wealth and income.
Via
Benzinga
Topics
Government
< Previous
1
2
3
4
Next >
